Live, attenuated varicella zoster vaccination of an immunocompromised patient

Journal of General Internal Medicine

Volumn 23, Issue 5, 2008, Pages 648-649

  Curtis, Kelly K ^a   Connolly, Megan K ^a   Northfelt, Donald W ^a  

^a MAYO CLINIC   (United States)

Author keywords

Adverse reactions; Immunocompromised patient; Varicella zoster vaccination

Indexed keywords

CEFALEXIN; FAMCICLOVIR; LIVE VACCINE; VARICELLA ZOSTER VACCINE; ANTINEOPLASTIC AGENT;

AGED; ARTICLE; BACTERIAL INFECTION; BREAST CANCER; CANCER CHEMOTHERAPY; CASE REPORT; FEMALE; HERPES ZOSTER; HUMAN; IMMUNOCOMPROMISED PATIENT; PHYSICIAN; RASH; RECURRENT CANCER; SKIN; VACCINATION; BREAST TUMOR; DRUG CONTRAINDICATION; GENERAL PRACTITIONER; IMMUNE DEFICIENCY; IMMUNOLOGY; PATHOGENICITY; VARICELLA ZOSTER VIRUS;

AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEMALE; HERPES ZOSTER; HERPES ZOSTER VACCINE; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; PHYSICIANS, FAMILY; VACCINES, ATTENUATED;

EID: 42449157532     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-008-0558-4     Document Type: Article

References (5)

1. Merck and Company. Zostavax® subcutaneous injection product information. 2006. Retrieved November 20, 2007 from: www.merck.com/product/usa/ pi_circulars/z/zostavax/zostavax_pi.pdf.
2. MMWR Quick Guide. Recommended adult immunization schedule - United States, October 2007-September 2008. MMWR 2007;56:Q1-Q4. Retrieved November 20, 2007 from http://www.cdc.gov/mmwr/pdf/wk/mm5641-Immunization.pdf.
3. Oxman M, Levin M, Johnson G, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352:2271-84.
4. Kraft J, Shaw J. Varicella infection caused by Oka strain vaccine in a heart transplant recipient. Arch Dermatol. 2006;142:943-5.
5. Centers for Disease Control and Prevention. Update on safety of herpes zoster vaccine. Retrieved November 20, 2007 from: www.cdc.gov/vaccines/recs/ acip/downloads/mtg-slides-jun07/12-zoster-chavez.pdf.